The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Warns Companies Illegally Marketing Products Containing 7 OH OncoDaily BPC 157 TB 500 Erectile Dysfunction Effects: What the Evidence and User Reports Actually Show fda warning bpc 157 peptide products New Details 157 FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner